• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荧光原位杂交法检测乳腺癌细针穿刺抽吸物中erbB2基因扩增情况

Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates.

作者信息

McManus D T, Patterson A H, Maxwell P, Humphreys M W, Anderson N H

机构信息

Immunohistochemistry and Molecular Pathology Laboratory, Department of Pathology, Belfast, Northern Ireland, UK.

出版信息

Mol Pathol. 1999 Apr;52(2):75-7. doi: 10.1136/mp.52.2.75.

DOI:10.1136/mp.52.2.75
PMID:10474685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC395677/
Abstract

AIM

To develop a method for the detection of amplification of the erbB2 oncogene in breast cancer fine needle aspirates using fluorescence in situ hybridisation (FISH) and to compare amplification with immunohistochemical detection of the erbB2 protein.

METHODS

A digoxigenin labelled probe to the erbB2 gene was hybridised to 15 aspirates prepared from operative breast cancer specimens. A chromosome 17 centromere probe was also hybridised to the aspirates either separately or in combination with the erbB2 probe. The aspirates were scored for erbB2 amplification and chromosome 17 centromere number. Subsequently, paraffin wax embedded sections of the tumours were stained with the antibody CB11 and scored for the presence of membrane staining.

RESULTS

Three of the 15 tumour aspirates showed high level amplification of erbB2 detected by FISH. These three tumours also showed chromosome 17 polysomy and diffuse membrane staining by immunohistochemistry.

CONCLUSIONS

FISH can be used to detect erbB2 amplification in fine needle aspirates and results correlate with conventional immunohistochemical staining. Difficulties were encountered in the visualisation of the signals in non-amplified cases without the use of specialised digital imaging.

摘要

目的

开发一种使用荧光原位杂交(FISH)检测乳腺癌细针穿刺抽吸物中erbB2癌基因扩增的方法,并将扩增情况与erbB2蛋白的免疫组织化学检测结果进行比较。

方法

将地高辛标记的erbB2基因探针与从手术切除的乳腺癌标本制备的15份抽吸物进行杂交。还将17号染色体着丝粒探针单独或与erbB2探针联合与抽吸物进行杂交。对抽吸物进行erbB2扩增和17号染色体着丝粒数量评分。随后,用抗体CB11对肿瘤的石蜡包埋切片进行染色,并对膜染色情况进行评分。

结果

15份肿瘤抽吸物中有3份通过FISH检测显示erbB2高水平扩增。这3个肿瘤还显示17号染色体多体性,并且免疫组织化学显示弥漫性膜染色。

结论

FISH可用于检测细针穿刺抽吸物中的erbB2扩增,结果与传统免疫组织化学染色相关。在不使用专门数字成像的情况下,非扩增病例的信号可视化存在困难。

相似文献

1
Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates.荧光原位杂交法检测乳腺癌细针穿刺抽吸物中erbB2基因扩增情况
Mol Pathol. 1999 Apr;52(2):75-7. doi: 10.1136/mp.52.2.75.
2
c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.通过对存档细胞学细针穿刺样本进行荧光原位杂交(FISH)分析乳腺癌中的c-erbB2/neu基因和17号染色体
Br J Cancer. 1999 May;80(3-4):519-25. doi: 10.1038/sj.bjc.6690387.
3
Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.在局部乳腺癌中使用荧光原位杂交与免疫组织化学分析ERBB2和TOP2A基因状态
Neoplasma. 2006;53(5):393-401.
4
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.显示ERBB2过表达的乳腺癌肿瘤中17号染色体多体性:一项使用荧光原位杂交和免疫组织化学对175例病例的研究
Breast Cancer Res. 2005;7(2):R267-73. doi: 10.1186/bcr996. Epub 2005 Jan 26.
5
Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ.
Int J Cancer. 1995 Feb 20;64(1):18-26. doi: 10.1002/ijc.2910640106.
6
PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.PGDS,一种结合显色原位杂交和免疫组织化学用于评估乳腺癌中ErbB2(HER2/neu)状态的新技术。
Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):316-24. doi: 10.1097/01.pai.0000213138.01536.2e.
7
HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer.通过荧光原位杂交在原发性乳腺癌细针穿刺抽吸物中检测到HER-2/neu扩增。
Ann Oncol. 2002 Sep;13(9):1398-403. doi: 10.1093/annonc/mdf217.
8
Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma.荧光原位杂交结果与免疫组织化学结果在评估乳腺癌中ERBB2(HER-2/neu)基因状态方面具有强相关性。
Mod Pathol. 2000 Nov;13(11):1238-43. doi: 10.1038/modpathol.3880228.
9
Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.乳腺癌中Her-2/Neu状态的测定:免疫组织化学与荧光原位杂交的比较分析
Mod Pathol. 2000 Jan;13(1):37-45. doi: 10.1038/modpathol.3880007.
10
Fluorescence in situ hybridization for HER-2/neu amplification of breast carcinoma in archival fine needle aspiration biopsy specimens.存档细针穿刺活检标本中乳腺癌HER-2/neu基因扩增的荧光原位杂交检测
Acta Cytol. 2005 Sep-Oct;49(5):471-6. doi: 10.1159/000326190.

引用本文的文献

1
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification.在HER2基因扩增检测中乳腺癌17号染色体单体性
Am J Cancer Res. 2015 Jun 15;5(7):2212-21. eCollection 2015.
2
Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab.通过用(64)Cu-DOTA-曲妥珠单抗进行非侵入性 PET 成像监测人卵巢癌对 17-DMAG 的治疗反应。
Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1510-9. doi: 10.1007/s00259-009-1158-1. Epub 2009 May 14.
3
Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.乳腺癌与17号染色体非整倍体:对致癌作用和治疗反应的影响
Lancet Oncol. 2009 Mar;10(3):267-77. doi: 10.1016/S1470-2045(09)70063-4.
4
Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor.热休克蛋白90抑制剂诱导的表皮生长因子受体降解的无创正电子发射断层显像
Mol Imaging Biol. 2008 Mar-Apr;10(2):99-106. doi: 10.1007/s11307-007-0123-2. Epub 2007 Dec 22.

本文引用的文献

1
ERBB2 oncogene in human breast cancer and its clinical significance.人乳腺癌中的ERBB2癌基因及其临床意义。
Eur J Cancer. 1998 May;34(6):791-808. doi: 10.1016/s0959-8049(97)10157-5.
2
Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.利用荧光原位杂交技术检测和定量人类乳腺癌存档材料中HER-2/neu基因扩增情况。
Oncogene. 1996 Jul 4;13(1):63-72.
3
Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies.用于检测乳腺肿瘤细针穿刺活检中erbB-2基因扩增的荧光原位杂交技术。
Acta Cytol. 1996 Mar-Apr;40(2):164-73. doi: 10.1159/000333683.
4
ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues.通过荧光差异聚合酶链反应在石蜡包埋的乳腺癌组织中检测到ERBB2基因扩增。
Int J Cancer. 1995 Oct 20;64(5):291-7. doi: 10.1002/ijc.2910640502.
5
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.人类乳腺癌:HER-2/neu癌基因扩增与复发及生存的相关性。
Science. 1987 Jan 9;235(4785):177-82. doi: 10.1126/science.3798106.
6
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.与表皮生长因子受体具有广泛同源性的酪氨酸激酶受体与neu癌基因位于同一染色体位置。
Science. 1985 Dec 6;230(4730):1132-9. doi: 10.1126/science.2999974.
7
Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.人类erbB - 2基因在正常和重排的17号染色体上定位于q12 - 21.32带。
Genomics. 1989 Apr;4(3):362-6. doi: 10.1016/0888-7543(89)90343-1.
8
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.通过荧光原位杂交分析乳腺癌中的ERBB2扩增。
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5321-5. doi: 10.1073/pnas.89.12.5321.
9
c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.c-erbB-2过表达与原位及浸润性乳腺癌的组织学类型
J Clin Pathol. 1992 Jan;45(1):16-20. doi: 10.1136/jcp.45.1.16.